Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallis

Showing results (361-370 of 390) with videos related to

Pageof 39
Sort By:
European Urology|September 7, 2020
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the FutureChristopher J D Wallis, James W F Catto, Antonio Finelli, et al.
JAMA|January 23, 2024
Functional Outcomes After Localized Prostate Cancer TreatmentBashir Al Hussein Al Awamlh, Christopher J D Wallis, David F Penson, et al.
Urologic Oncology|December 17, 2024
Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatmentAndrea A Lopez, Bashir Al Hussein Al Awamlh, Li-Ching Huang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 29, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancerGeoffrey T Gotto, Steven M Yip, Bobby Shayegan, et al.
Urologic Oncology|February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in CanadaBobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
JNCI Cancer Spectrum|October 18, 2022
The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate CancerDaniel D Joyce, Christopher J D Wallis, Li-Ching Huang, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series AnalysisEalia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2022
Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancerJacob E Tallman, Christopher J D Wallis, Li-Ching Huang, et al.
BJUI Compass|February 23, 2023
Association between body mass index and localized prostate cancer management and disease-specific quality of lifeNathan L Samora, Christopher J D Wallis, Li-Ching Huang, et al.
Pageof 39

Showing results (361-370 of 390) with videos related to

Sort By:
Pageof 39
European Urology|September 7, 2020
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the FutureChristopher J D Wallis, James W F Catto, Antonio Finelli, et al.
JAMA|January 23, 2024
Functional Outcomes After Localized Prostate Cancer TreatmentBashir Al Hussein Al Awamlh, Christopher J D Wallis, David F Penson, et al.
Urologic Oncology|December 17, 2024
Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatmentAndrea A Lopez, Bashir Al Hussein Al Awamlh, Li-Ching Huang, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 29, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancerGeoffrey T Gotto, Steven M Yip, Bobby Shayegan, et al.
Urologic Oncology|February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in CanadaBobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
JNCI Cancer Spectrum|October 18, 2022
The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate CancerDaniel D Joyce, Christopher J D Wallis, Li-Ching Huang, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series AnalysisEalia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2022
Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancerJacob E Tallman, Christopher J D Wallis, Li-Ching Huang, et al.
BJUI Compass|February 23, 2023
Association between body mass index and localized prostate cancer management and disease-specific quality of lifeNathan L Samora, Christopher J D Wallis, Li-Ching Huang, et al.
Pageof 39